These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24625468)

  • 1. An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway.
    Lu J; Hübner K; Nanjee MN; Brinton EA; Mazer NA
    PLoS Comput Biol; 2014 Mar; 10(3):e1003509. PubMed ID: 24625468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of HDL-modulating interventions for cardiovascular risk reduction using a systems pharmacology approach.
    Gadkar K; Lu J; Sahasranaman S; Davis J; Mazer NA; Ramanujan S
    J Lipid Res; 2016 Jan; 57(1):46-55. PubMed ID: 26522778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of HDL in Cholesterol Efflux and Reverse Cholesterol Transport].
    Ayaori M
    Rinsho Byori; 2016 Jan; 64(1):57-65. PubMed ID: 27192798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of high-density lipoprotein cholesterol metabolism and reverse cholesterol transport.
    Hersberger M; von Eckardstein A
    Handb Exp Pharmacol; 2005; (170):537-61. PubMed ID: 16596814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a role of CETP in HDL remodeling and cholesterol efflux: role of cysteine 13 of CETP.
    Maugeais C; Perez A; von der Mark E; Magg C; Pflieger P; Niesor EJ
    Biochim Biophys Acta; 2013 Nov; 1831(11):1644-50. PubMed ID: 23872476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brothers in Arms: ABCA1- and ABCG1-Mediated Cholesterol Efflux as Promising Targets in Cardiovascular Disease Treatment.
    Frambach SJCM; de Haas R; Smeitink JAM; Rongen GA; Russel FGM; Schirris TJJ
    Pharmacol Rev; 2020 Jan; 72(1):152-190. PubMed ID: 31831519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of plasma high-density lipoprotein levels by the ABCA1 transporter and the emerging role of high-density lipoprotein in the treatment of cardiovascular disease.
    Brewer HB; Remaley AT; Neufeld EB; Basso F; Joyce C
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1755-60. PubMed ID: 15319263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol.
    Tosheska Trajkovska K; Topuzovska S
    Anatol J Cardiol; 2017 Aug; 18(2):149-154. PubMed ID: 28766509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerobic exercise improves reverse cholesterol transport in cholesteryl ester transfer protein transgenic mice.
    Rocco DD; Okuda LS; Pinto RS; Ferreira FD; Kubo SK; Nakandakare ER; Quintão EC; Catanozi S; Passarelli M
    Lipids; 2011 Jul; 46(7):617-25. PubMed ID: 21479674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways.
    Takiguchi S; Ayaori M; Yakushiji E; Nishida T; Nakaya K; Sasaki M; Iizuka M; Uto-Kondo H; Terao Y; Yogo M; Komatsu T; Ogura M; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1454-1467. PubMed ID: 29748333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
    Cavelier C; Lorenzi I; Rohrer L; von Eckardstein A
    Biochim Biophys Acta; 2006 Jul; 1761(7):655-66. PubMed ID: 16798073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.
    Tchoua U; D'Souza W; Mukhamedova N; Blum D; Niesor E; Mizrahi J; Maugeais C; Sviridov D
    Cardiovasc Res; 2008 Mar; 77(4):732-9. PubMed ID: 18056760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.
    van Capelleveen JC; Kastelein JJ; Zwinderman AH; van Deventer SJ; Collins HL; Adelman SJ; Round P; Ford J; Rader DJ; Hovingh GK
    J Clin Lipidol; 2016; 10(5):1137-1144.e3. PubMed ID: 27678430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation.
    Yamashita S; Matsuzawa Y
    Curr Opin Lipidol; 2016 Oct; 27(5):459-72. PubMed ID: 27454452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNAs in lipoprotein metabolism and cardiometabolic disorders.
    Rotllan N; Price N; Pati P; Goedeke L; Fernández-Hernando C
    Atherosclerosis; 2016 Mar; 246():352-60. PubMed ID: 26828754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors.
    Johns DG; Duffy J; Fisher T; Hubbard BK; Forrest MJ
    Drugs; 2012 Mar; 72(4):491-507. PubMed ID: 22356288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor.
    Bashore AC; Liu M; Key CC; Boudyguina E; Wang X; Carroll CM; Sawyer JK; Mullick AE; Lee RG; Macauley SL; Parks JS
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1747-1761. PubMed ID: 31167565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.
    Ye D; Lammers B; Zhao Y; Meurs I; Van Berkel TJ; Van Eck M
    Curr Drug Targets; 2011 May; 12(5):647-60. PubMed ID: 21039336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting high-density lipoproteins: update on a promising therapy.
    Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
    Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.